Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Laminin subunit alpha-3 is an essential extracellular matrix glycoprotein encoded by the LAMA3 gene, primarily functioning as the alpha chain of laminin-332 (formerly known as laminin-5)[1][5][7]. Laminins are heterotrimeric proteins (alpha, beta, gamma subunits) fundamental to the structural integrity and function of basement membranes across many tissues, particularly the skin, where they contribute to strength, resilience, and cell-matrix adhesion[3][5]. Multiple transcript variants of LAMA3 generate different isoforms involved in cell adhesion, migration, proliferation, basement membrane assembly, and wound healing[1][3]. Mutations in LAMA3 cause severe genetic blistering diseases such as junctional epidermolysis bullosa and have been implicated in cancer development and progression, being variably up- or down-regulated in different tumor types[2][5]. LAMA3 interacts with other laminin subunits (gamma-2 and beta-3) and cellular integrins, playing a central role in epithelial homeostasis and tissue repair[4][3]. Dysregulation of LAMA3 is implicated in both inherited skin fragility disorders and as a biomarker for prognosis and therapeutic targeting in cancer[2].
Not applicable (no direct drugs); conceptually, inhibitors or modulators would affect cell adhesion, ECM organization, or tumor cell motility/migration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Laminin subunit alpha-3 (LAMA3).